Carbon Dioxide As Contrast Medium to Guide Endovascular Aortic Aneurysm Repair
Overview
General Surgery
Authors
Affiliations
Background: Iodine contrast medium (ICM) is considered to be gold standard in endovascular procedures, but its nephrotoxicity and hypersensitivity limit the widespread use. Carbon dioxide (CO) is considered as an alternative for endovascular procedures in patients with contraindication to ICM. However, no studies have compared the outcomes of endovascular aneurysm repair (EVAR) performed with ICM or CO among patients with no contraindication to ICM.
Methods: From May 2012 to April 2014, 36 patients with abdominal aortic aneurysms underwent EVAR in a prospective, randomized, and controlled study. Patients were randomized into 2 groups, CO or ICM group.
Results: We were able to perform the proposed procedures in all patients in this study. There were no conversions to open surgery and no CO-related complications. Endovascular material costs, duration of surgery, and time of fluoroscopy were similar between groups, and the cost of the contrast media was smaller in the CO group than in the ICM group. Among CO group procedures, 62.5% of the patients needed ICM complementary use.
Conclusions: The use of CO as a contrast medium for EVAR is an alternative in patients with no restriction for ICM, with similar outcomes when compared to ICM, regarding duration of surgery, duration of fluoroscopy, and endovascular material costs. Using CO, there were no changes in creatinine clearance and no risk of hypersensitivity reactions; moreover, there was a reduction in contrast-related costs for EVAR procedures. However, in our study, additional use of ICM to visualize the internal iliac artery was needed in most procedures.
Spath P, Caputo S, Campana F, Gallitto E, Pini R, Mascoli C J Clin Med. 2024; 13(16).
PMID: 39200776 PMC: 11354707. DOI: 10.3390/jcm13164634.
Teivelis M, da Silva M, Stabellini N, Diamante Leiderman D, Szlejf C, Amaro E J Vasc Bras. 2022; 21:e20210087.
PMID: 36003127 PMC: 9387923. DOI: 10.1590/1677-5449.202100872.
Anacleto A, Morales M, Teivelis M, da Silva M, Portugal M, Szlejf C Braz J Cardiovasc Surg. 2022; 37(5):622-627.
PMID: 35657309 PMC: 9670342. DOI: 10.21470/1678-9741-2021-0291.
Portugal M, Teivelis M, da Silva M, Fioranelli A, Szlejf C, Amaro-Junior E Clinics (Sao Paulo). 2021; 76:e2890.
PMID: 34287481 PMC: 8266170. DOI: 10.6061/clinics/2021/e2890.
Use of carbon dioxide for therapeutic decision-making in endoleaks: a case report.
Megale A, Mendes C, Teivelis M, Faustino C, Souza K, Wolosker N J Vasc Bras. 2021; 19:e20200060.
PMID: 34211518 PMC: 8218004. DOI: 10.1590/1677-5449.200060.